Drug profile · INN
nitric oxide
INOMAX
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
nitric oxide (INOMAX) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12286405
Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
granted -
US 12251449
Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase
granted -
US 12213973
Bacterial nitric oxide synthase inhibitors
granted -
US 12083113
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 11998513
Two-part nitric oxide generating topical compositions
granted -
US 11439632
Use of neuronal nitric oxide synthase inhibitors for immunotherapy in melanoma patients
granted -
US 11439609
Nitric oxide releasing PLGA microspheres for biomedical applications
granted -
US 11413420
Nitric oxide delivery devices
granted
Frequently asked questions
What is nitric oxide?
nitric oxide (INOMAX) is an FDA-listed pharmaceutical active ingredient. Route of administration: inhalation. Current US regulatory status: approved.
What is the brand name for nitric oxide?
INOMAX is a marketed brand name for nitric oxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nitric oxide?
nitric oxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.